New Vaccination Decision-Making Tool for 2023 Respiratory Season Now Available
The new monovalent COVID-19 vaccines recently authorized by the Food and Drug Administration (FDA) and recommended by the Centers for Disease Control and Prevention (CDC) for all people aged 5 and over are now available. This week, the National Adult and Influenza Immunization Summit (NAIIS) released a new resource, Fall 2023 Respiratory Season Vaccination Decision Making for People 60 and Over, that provides vaccine coadministration strategies based on various scenarios. The tool is available here.
Contact: Amy Nelson, firstname.lastname@example.org, 518-867-8383 ext. 146